Follow The Filings

BOLD Boundless Bio Inc.

Health Care, filed as BOUNDLESS BIO INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by BOLD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BOLD insider trades
  • $1.9M bought by 1 insider
  • $134K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kevin Tang 10% owner, +1 joint filer
    Buy
    $350K 149,474 shares at $2.34 +5.3% to stake
    Traded Oct 16–20 Filed Oct 20
    ↗
  2. Kevin Tang 10% owner, +1 joint filer
    Sale
    $54K 18,300 shares at $2.97 0.6% of stake
    Traded Aug 26 Filed Aug 28
    ↗
  3. Kevin Tang 10% owner, +1 joint filer
    Buy
    $12K 4,863 shares at $2.44 +0.2% to stake
    Traded Jul 17–21 Filed Jul 21
    ↗
  4. Kevin Tang 10% owner, +1 joint filer
    Buy
    $156K 63,969 shares at $2.43 +2.3% to stake
    Traded Jul 14–16 Filed Jul 16
    ↗
  5. Kevin Tang 10% owner, +1 joint filer
    Buy
    $222K 91,585 shares at $2.42 +3.4% to stake
    Traded Jul 9–13 Filed Jul 13
    ↗
  6. Kevin Tang 10% owner, +1 joint filer
    Buy
    $142K 57,210 shares at $2.48 +2.2% to stake
    Traded Jul 6–8 Filed Jul 8
    ↗
  7. Keith Crandell 10% owner, +4 joint filers
    Sale
    $40K 16,000 shares at $2.49 100% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  8. Kevin Tang 10% owner, +1 joint filer
    Buy
    $269K 107,463 shares at $2.50 +4.2% to stake
    Traded Jun 30–Jul 2 Filed Jul 2
    ↗
  9. Kevin Tang 10% owner, +1 joint filer
    Buy
    $715K 286,333 shares at $2.50 +13% to stake
    Traded Jun 25–29 Filed Jun 29
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.05,3.02,5.01,5.02,7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 1.02,2.03 Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Net income -$65.36M -$58.2M

Balance sheet

Metric FY2024 FY2025
Total current assets $154.39M $109.61M
Total non-current assets * $52.02M $47.45M
Total assets $206.41M $157.06M
Total current liabilities $8.14M $12.54M
Total non-current liabilities * $47.63M $45.87M
Total equity $150.64M $98.65M

Cash flow

Metric FY2024 FY2025
Cash from operations -$60.84M -$46.66M
Cash from investing -$26.1M $37.8M
Cash from financing $89.82M $0.141M
Net change in cash $2.88M -$8.72M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q1 2024

Period archive